Kang Haggerty News
Edward Kang and Kandis Kovalsky of Kang Haggerty recently participated in a congressional roundtable hosted by the House Committee on Veterans’ Affairs, titled “Profit Over Quality: Examining the Effects of Private Equity on Veteran Healthcare.” The Capitol Hill event brought together legal experts, public health scholars, and policymakers to explore how profit-driven healthcare models—particularly those involving private equity—affect cost, access, and quality of care for veterans.
Edward Kang and Kandis Kovalsky of Kang Haggerty
House Committee on Veterans’ Affairs Ranking Member Mark Takano of California.
Kang Haggerty was invited for its pivotal role in a landmark False Claims Act (FCA) whistleblower case against Insys Therapeutics, a pharmaceutical company known for its unlawful marketing of Subsys, a fentanyl-based painkiller. Edward and Kandis shared insights on the power of the FCA to combat healthcare fraud and protect public health.
The roundtable featured prominent voices from Harvard, Brown, Penn, and the University of Chicago, and included Pennsylvania Senator Amanda Cappelletti and Congressman Chris Deluzio. The discussion underscored the urgent need for transparency and accountability in veteran healthcare systems. The roundtable was convened by the House Committee on Veterans’ Affairs, led by Ranking Member Mark Takano of California.